ES2193133T3 - Uso de peptidos derivados de los genes e6 y e7 de hpv-16 para fines. - Google Patents
Uso de peptidos derivados de los genes e6 y e7 de hpv-16 para fines.Info
- Publication number
- ES2193133T3 ES2193133T3 ES92110367T ES92110367T ES2193133T3 ES 2193133 T3 ES2193133 T3 ES 2193133T3 ES 92110367 T ES92110367 T ES 92110367T ES 92110367 T ES92110367 T ES 92110367T ES 2193133 T3 ES2193133 T3 ES 2193133T3
- Authority
- ES
- Spain
- Prior art keywords
- hpv
- genes
- purposes
- peptides derived
- fot
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/084—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
LA PRESENTE INVENCION ESTA RELACIONADA CON EL USO DE LOS PEPTIDOS DERIVADOS DEL GEN HUMANO PAILLOMAVIRUS 16 (HPV-16) E7 PARA LA IDENTIFICACION DIAGNOSTICA DEL CANCER CERVICAL INVASIVO ASOCIADO AL HPV-16.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP91111720 | 1991-07-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2193133T3 true ES2193133T3 (es) | 2003-11-01 |
Family
ID=8206929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92110367T Expired - Lifetime ES2193133T3 (es) | 1991-07-13 | 1992-06-19 | Uso de peptidos derivados de los genes e6 y e7 de hpv-16 para fines. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5629161A (es) |
EP (1) | EP0523391B1 (es) |
JP (1) | JP3366350B2 (es) |
AT (1) | ATE234860T1 (es) |
AU (1) | AU667470B2 (es) |
CA (1) | CA2073616C (es) |
DE (1) | DE69232963T2 (es) |
DK (1) | DK0523391T3 (es) |
ES (1) | ES2193133T3 (es) |
PT (1) | PT523391E (es) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2097916C (en) * | 1990-12-12 | 2001-08-21 | Robert Tindle | Subunit papillomavirus vaccine and peptides for use therein |
US5736318A (en) * | 1995-03-17 | 1998-04-07 | President And Fellows Of Harvard College | Method and kit for evaluating human papillomavirus transformed cells |
DE19925235A1 (de) | 1999-06-01 | 2000-12-07 | Medigene Ag | Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie |
DE19925199A1 (de) | 1999-06-01 | 2000-12-07 | Medigene Ag | Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie |
FR2794370B1 (fr) | 1999-06-03 | 2003-10-17 | Biovector Therapeutics | Fragments proteiques polyepitopiques, leur obtention et leurs utilisations notamment en vaccination |
US6641994B2 (en) | 1999-08-25 | 2003-11-04 | Pharmacia & Upjohn Company | Methods of identifying anti-viral agents |
US6200746B1 (en) | 1999-08-25 | 2001-03-13 | Pharmacia & Upjohn Company | Methods of identifying anti-viral agents |
JP2003509035A (ja) * | 1999-09-16 | 2003-03-11 | ザイコス インク. | ポリエピトープポリペプチドをコードする核酸 |
US20050100928A1 (en) * | 1999-09-16 | 2005-05-12 | Zycos Inc., A Delaware Corporation | Nucleic acids encoding polyepitope polypeptides |
FR2794371B1 (fr) * | 1999-10-07 | 2004-06-18 | Biovector Therapeutics | Fragments proteiquespolyepitopiques, leur obtention et leurs utilisations notamment en vaccination |
US8128922B2 (en) * | 1999-10-20 | 2012-03-06 | Johns Hopkins University | Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen |
CN1433428A (zh) * | 2000-04-05 | 2003-07-30 | 冲击诊断公司 | 辨别人乳头瘤病毒的免疫学方法 |
AU2001290520A1 (en) * | 2000-08-01 | 2002-02-13 | The Johns Hokpins University | Intercellular transport protein linked to an antigen as a molecular vaccine |
ES2454640T3 (es) * | 2000-08-03 | 2014-04-11 | Johns Hopkins University | Vacuna molecular que lleva unida un polipéptido de chaperona del retículo endoplasmático a un antígeno |
US7312041B2 (en) | 2001-02-16 | 2007-12-25 | Arbor Vita Corporation | Methods of diagnosing cervical cancer |
US6933123B2 (en) * | 2001-04-05 | 2005-08-23 | Yao Xiong Hu | Peptides from the E2, E6, and E7 proteins of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers |
FR2824326B1 (fr) * | 2001-05-04 | 2004-03-19 | Commissariat Energie Atomique | Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications |
US20060147906A1 (en) * | 2002-03-22 | 2006-07-06 | Amynon Biotech Gmbh | Anti-hpv-16 e7 antibodies and their use |
EP1537415B1 (en) * | 2002-09-09 | 2008-12-17 | Arbor Vita Corporation | Methods of diagnosing cervical cancer |
EP1644048B1 (en) * | 2003-05-05 | 2015-04-29 | Johns Hopkins University | Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein |
LT5228B (lt) | 2003-07-16 | 2005-06-27 | Uždaroji akcinė bendrovė Melofarma | Gimdos kaklelio displazijų ir vėžio, susijusių su žmogaus papilomos virusais ankstyvos diagnostikos in vitro būdas |
AU2004308964B2 (en) * | 2003-12-23 | 2010-09-16 | Arbor Vita Corporation | Antibodies for oncogenic strains of HPV and methods of their use |
CA2594040A1 (en) * | 2005-01-06 | 2006-07-13 | The Johns Hopkins University | Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines |
EP1846026A4 (en) * | 2005-01-26 | 2008-07-02 | Univ Johns Hopkins | ANTICANCER DNA VACCINE USING PLASMID CODING ANTIGEN AND CALRETICULIN SUCH AS MUTANT ONCOPROTEINS |
US7732166B2 (en) * | 2005-11-15 | 2010-06-08 | Oncohealth Corporation | Detection method for human pappilomavirus (HPV) and its application in cervical cancer |
US7972776B2 (en) * | 2005-11-15 | 2011-07-05 | Oncohealth Corporation | Protein chips for HPV detection |
US20100330105A1 (en) * | 2006-08-22 | 2010-12-30 | John Hopkins University | Anticancer Combination Therapies |
WO2010129821A1 (en) | 2009-05-07 | 2010-11-11 | Oncohealth Corporation | Identification of high grade or ≥cin2 for early stages and late stages detection, screening, and diagnosis of human papillomavirus (hpv) and hpv-associated cancers |
US8968995B2 (en) * | 2008-11-12 | 2015-03-03 | Oncohealth Corp. | Detection, screening, and diagnosis of HPV-associated cancers |
US20100003704A1 (en) * | 2008-06-13 | 2010-01-07 | Shuling Cheng | IN SITU detection of early stages and late stages HPV infection |
US9085638B2 (en) | 2007-03-07 | 2015-07-21 | The Johns Hopkins University | DNA vaccine enhancement with MHC class II activators |
US20080260765A1 (en) * | 2007-03-15 | 2008-10-23 | Johns Hopkins University | HPV DNA Vaccines and Methods of Use Thereof |
WO2008124091A2 (en) * | 2007-04-05 | 2008-10-16 | Genera Biosystems Limited | Compositions and methods of detection |
AU2015213420B2 (en) * | 2007-05-31 | 2017-02-16 | Isa Pharmaceuticals B.V. | HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccines |
ES2496916T3 (es) | 2007-05-31 | 2014-09-22 | Academisch Ziekenhuis Leiden H.O.D.N. Lumc | Epítopo de HPV al que se dirigen células T que infiltran tumores malignos cervicales para su uso en vacunas |
US20090285861A1 (en) * | 2008-04-17 | 2009-11-19 | Tzyy-Choou Wu | Tumor cell-based cancer immunotherapeutic compositions and methods |
WO2011084598A1 (en) | 2010-01-08 | 2011-07-14 | Oncohealth Corporation | High throughput cell-based hpv immunoassays for diagnosis and screening of hpv-associated cancers |
CN104004067B (zh) * | 2013-02-22 | 2017-09-01 | 艾托金生物医药(苏州)有限公司 | 用于检测抗人乳头瘤病毒抗体的抗原及相关免疫检测试剂盒 |
CN109053879B (zh) * | 2018-08-22 | 2020-12-25 | 深圳市宝安区中心医院 | 一种治疗宫颈癌的scFv抗体及其应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4777239A (en) * | 1986-07-10 | 1988-10-11 | The Board Of Trustees Of The Leland Stanford Junior University | Diagnostic peptides of human papilloma virus |
US5180806A (en) * | 1988-05-16 | 1993-01-19 | The Scripps Research Institute | Polypeptides and compositions of human papillomavirus latent proteins, diagnostic systems and methods |
FR2641081A1 (es) * | 1988-12-23 | 1990-06-29 | Medgenix Group | |
DE3907721A1 (de) * | 1989-03-10 | 1990-09-20 | Behringwerke Ag | Immunogene regionen auf dem e7-protein des humanen papillomvierus typ 16 |
US5045447A (en) * | 1989-03-15 | 1991-09-03 | Minson Anthony C | Method of producing antibodies to HPV |
PT97073A (pt) * | 1990-03-20 | 1991-10-31 | Behringwerke Ag | Processo para a preparacao de epitopos soro-reactivos de proteinas de papillomavirus 16 humano (hpv) |
SE9001705D0 (sv) * | 1990-05-11 | 1990-05-11 | Medscand Ab | Saett foer diagnostik av virusbaerande tumoerer genom immunoassay |
WO1992005248A1 (en) * | 1990-09-26 | 1992-04-02 | Bristol-Myers Squibb Company | Human papilloma viral protein expression for use in vaccine compositions |
-
1992
- 1992-06-19 AT AT92110367T patent/ATE234860T1/de not_active IP Right Cessation
- 1992-06-19 DK DK92110367T patent/DK0523391T3/da active
- 1992-06-19 ES ES92110367T patent/ES2193133T3/es not_active Expired - Lifetime
- 1992-06-19 EP EP92110367A patent/EP0523391B1/en not_active Expired - Lifetime
- 1992-06-19 PT PT92110367T patent/PT523391E/pt unknown
- 1992-06-19 DE DE69232963T patent/DE69232963T2/de not_active Expired - Fee Related
- 1992-07-10 AU AU19590/92A patent/AU667470B2/en not_active Ceased
- 1992-07-10 CA CA002073616A patent/CA2073616C/en not_active Expired - Fee Related
- 1992-07-13 JP JP20840792A patent/JP3366350B2/ja not_active Expired - Fee Related
-
1994
- 1994-12-23 US US08/363,586 patent/US5629161A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH06169781A (ja) | 1994-06-21 |
PT523391E (pt) | 2003-08-29 |
DE69232963D1 (de) | 2003-04-24 |
EP0523391A1 (en) | 1993-01-20 |
JP3366350B2 (ja) | 2003-01-14 |
EP0523391B1 (en) | 2003-03-19 |
CA2073616C (en) | 2003-11-04 |
DK0523391T3 (da) | 2003-06-23 |
DE69232963T2 (de) | 2004-03-04 |
AU667470B2 (en) | 1996-03-28 |
AU1959092A (en) | 1993-01-14 |
ATE234860T1 (de) | 2003-04-15 |
US5629161A (en) | 1997-05-13 |
CA2073616A1 (en) | 1993-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2193133T3 (es) | Uso de peptidos derivados de los genes e6 y e7 de hpv-16 para fines. | |
NO20000850L (no) | Vaksine | |
NL300272I1 (nl) | DNA dat humaan papillomavirus type 18 codeert. | |
DE69830927D1 (de) | Bewertung von humaner papillomvirus verwandter krankheit | |
HUP9801826A2 (hu) | HER-2/neu-fehérje intracelluláris doménje, és alkalmazása malignitások megelőzésére és kezelésére | |
DE69230206D1 (de) | Rekombinante derivate des menschlichen faktors viii | |
DE69535274D1 (de) | Verwendung eines menschlichen interleukin-11 rezeptors | |
ATE107859T1 (de) | Verwendung von antiprogestomimetika zur stimulierung des eisprungs. | |
GR3006834T3 (es) | ||
DE69128239D1 (de) | DNA SEGMENT DES HERPESVIRUS DER MAREK-KRANKHEIT, WELCHES FÜR DAS GLYKOPROTEIN gE KODIERT | |
ITRM910146U1 (it) | Strumento chirurgico per l'introduzione di protesi peniene. | |
TR199800876T2 (xx) | Yeni ara �r�nler ve bunlar�n N,N'-k�pr�l� bisindolilmaleimidlerin elde edilmesinde kullan�m�. | |
NO962248D0 (no) | Joderte bifenylderivater og deres diagnostiske anvendelse | |
MX9307998A (es) | Proteina de virus de varicela-zoster, derivados de la misma y vacuna que la contiene. | |
ES2140402T3 (es) | Inhibidor nuclear i-92 y su uso para la produccion de un medicamento. | |
RU93040882A (ru) | Способ определения возрастных изменений кожи | |
ECSP961747A (es) | Producto del gen de la obesidad | |
ITMI940414A0 (it) | Procedimento per la coniugazione di proteine di interesse terapeutico o diagnostico | |
IT9020755A0 (it) | Procedimento per la identificazione e la sintesi di siti di interazione di proteine interagenti | |
ITRM940468A0 (it) | "impiego di esteruretani per ls riconcia". |